Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do steroid shots work as well for carpal tunnel in diabetics?

NCT ID NCT07433257

Symptom relief Sponsor: Haydarpasa Numune Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will give a steroid and numbing injection to 60 people with carpal tunnel syndrome, half of whom also have type 2 diabetes. Researchers will track pain, nerve function, and hand strength for 12 weeks to see if the diabetes group recovers as well as those without diabetes. The goal is to understand if this common treatment works similarly for both groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
triamcinolone acetonide (a corticosteroid) plus lidocaine (a local anesthetic)
What this could lead to
If successful, this study could show that a simple injection works equally well for people with diabetes, helping guide better treatment for this group.
What could go wrong
This is a small, observational study with only 60 participants, so results may not apply to everyone. It does not test a new treatment, just compares recovery in two groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who presented to the Physical Medicine and Rehabilitation outpatient clinic with clinical symptoms consistent with carpal tunnel syndrome and were diagnosed with mild-to-moderate carpal tunnel syndrome

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Carpal Tunnel Syndrome with Type 2 Diabetes Mellitus Group (Group 1): * Age between 18 and 75 years * Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months * Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings * Diagnosis of type 2 diabetes mellitus * Regulated blood glucose levels, defined as hemoglobin A1c (HbA1c) \< 7% * Idiopathic Carpal Tunnel Syndrome Group (Group 2): * Age between 18 and 75 years * Presence of clinical symptoms consistent with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months * Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings * No diagnosis of diabetes mellitus Exclusion Criteria * Severe carpal tunnel syndrome based on electrophysiological findings * Presence of polyneuropathy, cervical radiculopathy, brachial plexopathy, or thoracic outlet syndrome * Uncontrolled blood glucose levels in the diabetic group (hemoglobin A1c ≥ 7%) * Presence of another systemic disease, other than diabetes mellitus, that may cause carpal tunnel syndrome * Presence of a rheumatological disease * History of wrist surgery * Less than 6 months since a local corticosteroid injection for carpal tunnel syndrome * Less than 3 months since completion of a physical therapy program for carpal tunnel syndrome * Infection at the intended injection site * Presence of malignancy * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carpal tunnel syndrome (CTS) Type 2 diabetes mellitus (T2DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul Haydarpasa Numune Training and Research Hospital

    RECRUITING

    Istanbul, Istanbul, 34668, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.